Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2013, Article ID 319201, 9 pages
http://dx.doi.org/10.1155/2013/319201
Research Article

Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple Sclerosis

1Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh Medical Center, S848 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA
2Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
3Division of Gastroenterology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
4Neuroimmunology/Multiple Sclerosis Division, Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA

Received 12 June 2013; Accepted 14 August 2013

Academic Editor: Mark S. Freedman

Copyright © 2013 David J. Levinthal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Edward J Fox, Alberto Vasquez, William Grainger, Tina S Ma, Christian von Hehn, John Walsh, Jie Li, and Javier Zambrano, “Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).,” International journal of MS care, vol. 18, no. 1, pp. 9–18, . View at Publisher · View at Google Scholar
  • Sheila Tsau, Steven M Levine, Thomas M Yankee, Brooks L Parker, Aaron C Ericsson, and Scott A Sands, “The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice,” BMC Research Notes, vol. 7, no. 1, 2014. View at Publisher · View at Google Scholar
  • Ana Paula Kallaur, Josiane Lopes, Sayonara Rangel Oliveira, Andrea Name Colado Simão, Edna Maria Vissoci Reiche, Elaine Regina Delicato de Almeida, Helena Kaminami Morimoto, Wildea Lice Carvalho Jennings de Pereira, Daniele Frizon Alfieri, Sueli Donizete Borelli, Domacio Ramon Kaimen-Maciel, and Michael Maes, “Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation,” Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  • Alexandra Pintér, Domonkos Cseh, Adrienn Sárközi, Ben M. Illigens, and Timo Siepmann, “Autonomic dysregulation in multiple sclerosis,” International Journal of Molecular Sciences, vol. 16, no. 8, pp. 16920–16952, 2015. View at Publisher · View at Google Scholar
  • Xiao-Li Guan, Hui Wang, Hai-Shan Huang, and Ling Meng, “Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis,” Neurological Sciences, vol. 36, no. 5, pp. 671–681, 2015. View at Publisher · View at Google Scholar
  • Ruth Ann Marrie, Stephen Reingold, Jeffrey Cohen, Olaf Stuve, Maria Trojano, Per Soelberg Sorensen, Gary Cutter, and Nadia Reider, “The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review,” Multiple Sclerosis Journal, vol. 21, no. 3, pp. 305–317, 2015. View at Publisher · View at Google Scholar
  • Ruth Ann Marrie, Nadia Reider, Olaf Stuve, Maria Trojano, Per Soelberg Sorensen, Gary R. Cutter, Stephen C. Reingold, and Jeffrey Cohen, “The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic,” Multiple Sclerosis Journal, vol. 21, no. 3, pp. 332–341, 2015. View at Publisher · View at Google Scholar
  • Ruth Ann Marrie, Nadia Reider, Jeffrey Cohen, Olaf Stuve, Per S. Sorensen, Gary Cutter, Stephen C. Reingold, and Maria Trojano, “A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis,” Multiple Sclerosis Journal, vol. 21, no. 3, pp. 282–293, 2015. View at Publisher · View at Google Scholar
  • Ruth Ann Marrie, Jeffrey Cohen, Olaf Stuve, Maria Trojano, Per Soelberg Sorensen, Stephen Reingold, Gary Cutter, and Nadia Reider, “A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview,” Multiple Sclerosis Journal, vol. 21, no. 3, pp. 263–281, 2015. View at Publisher · View at Google Scholar
  • Marie Wunsch, Samir Jabari, Barbara Voussen, Michael Enders, Shanthi Srinivasan, François Cossais, Thilo Wedel, Martina Boettner, Anna Schwarz, Linda Weyer, Oktay Göcer, Michael Schroeter, Mathias Maeurer, Matthias Woenckhaus, Karolin Pollok, Helena Radbruch, Luisa Klotz, Claus-Jürgen Scholz, Joachim Nickel, Andreas Friebe, Klaus Addicks, Süleyman Ergün, Paul V. Lehmann, and Stefanie Kuerten, “The enteric nervous system is a potential autoimmune target in multiple sclerosis,” Acta Neuropathologica, 2017. View at Publisher · View at Google Scholar
  • Carlos R Camara-Lemarroy, Luanne M Metz, and V Wee Yong, “Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome,” World Journal of Gastroenterology, vol. 24, no. 37, pp. 4217–4223, 2018. View at Publisher · View at Google Scholar
  • I. N. Abdurasulova, E. A. Tarasova, I. G. Nikiforova, A. G. Il'ves, E. V. Ivashkova, A. V. Matsulevich, A. E. Tatarinov, L. V. Shangina, E. I. Ermolenko, V. M. Klimenko, I. D. Stolyarov, and A. N. Suvorov, “The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT,” Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, vol. 118, no. 8, pp. 62, 2018. View at Publisher · View at Google Scholar
  • Wylezinski, Gray, Polk, Harmata, and Spurlock, “Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes,” Journal of Clinical Medicine, vol. 8, no. 4, pp. 493, 2019. View at Publisher · View at Google Scholar